CNTX Context Therapeutics Inc
Company Analysis
Latest News
🟢 Context Therapeutics is trading 8.26% up in after-hours trading with no clear company-specific catalyst
Context Therapeutics is trading at $0.38 (+8.26%) after-hours, with no major September 14, 2026 company announcement identified. - The latest release, dated...
🟢 Context Therapeutics is trading 6.11% up today despite a weaker broader market
Context Therapeutics is trading 6.11% up at $0.37 on September 14, 2026, with no clear company-specific catalyst or major announcement identified. - The...
🟢 Context Therapeutics is trading 7% up in after-hours trading with no clear company-specific catalyst
Context Therapeutics is trading 7.02% up at $0.38 after the September 11, 2026 regular session closed at $0.35; the move appears aligned with broader risk-on...
🔴 Context Therapeutics is trading 5.66% down in after-hours trading with no identified company-specific catalyst
Context Therapeutics is trading 5.66% down at $0.35 in after-hours trading, with no identified company-specific catalyst. - No company-specific announcement,...
🔴 Context Therapeutics is trading 5% down in pre-market with no clear company-specific catalyst identified
Context Therapeutics is trading at $0.34 (-5.17%), with no clear company-specific announcement identified for September 8, 2026. - No fresh earnings,...
🔴 Context Therapeutics is trading 5% down today as biotech and broader markets weaken
Context Therapeutics is trading 5.21% down at $0.37, with the decline appearing aligned with broad risk-off trading. - No new company-specific announcement...
🔴 Context Therapeutics falls 6.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Context Therapeutics is trading 8% up in pre-market amid broader market gains
Context Therapeutics is trading 8% up at $0.46 in pre-market, with the move appearing aligned with broader risk-on sentiment rather than a confirmed...
🔴 Context Therapeutics is trading 5.8% down in pre-market with no confirmed company-specific catalyst
Context Therapeutics is trading at $0.41, down -5.83% in pre-market on August 26, 2026, with no confirmed company-specific catalyst identified. - The latest...
🔴 Context Therapeutics is trading 11.15% down today with specific cause unclear
Context Therapeutics is trading at $0.41, down 11.15%, after opening-session weakness on August 25, 2026, with no specific cause confirmed. - No new...
🔴 Context Therapeutics is trading 5.5% down today with no clear catalyst
Context Therapeutics is trading 5.5% down at $0.44 after opening-session weakness, with no clear catalyst confirmed. - The stock fell 6.94% to $0.47 on August...
🟢 Context Therapeutics is trading 5.46% up in pre-market with no confirmed company-specific catalyst identified
Context Therapeutics is trading at $0.49, up 5.46%, after no confirmed company-specific announcement or overnight catalyst was identified for the pre-market...
🔴 Context Therapeutics is trading 5% down today; no confirmed company-specific catalyst
On August 24, 2026, Context Therapeutics is trading at $0.47, down -5.08% (5% down), with no confirmed company-specific catalyst identified. - The latest...
🔴 Context Therapeutics is trading 6% down in pre-market with no confirmed company-specific catalyst
Context Therapeutics is trading 6.02% down at $0.47 after no confirmed company-specific catalyst was identified for August 24, 2026. - The latest...
🟢 Context Therapeutics is trading 8% up in pre-market with no confirmed catalyst
Context Therapeutics is trading at $0.54, up 7.98%, after no confirmed company-specific catalyst was identified for August 24, 2026. - The latest...
🔴 Context Therapeutics is trading 6.97% down in pre-market with no confirmed company-specific catalyst identified
Context Therapeutics is trading 6.97% down at $0.48, with no company-specific announcement or confirmed overnight catalyst identified for August 21, 2026. -...
🟢 Context Therapeutics is trading 5% up today amid trading volatility
Context Therapeutics is trading 5.13% up at $0.51, with the gain appearing to reflect trading volatility rather than a confirmed fundamental catalyst. - No...
🔴 Context Therapeutics is trading 6.73% down today as the specific cause remains unclear
Context Therapeutics is trading 6.73% down now at $0.46, with the specific cause unclear and no confirmed company-specific announcement dated August 19,...
🔴 Context Therapeutics is trading 5.26% down today as Nasdaq Composite falls 1.32%
Context Therapeutics is trading 5.26% down at $0.50 amid broader market weakness, with the Nasdaq Composite down 1.32% and the S&P 500 down 0.58%. - No fresh...
🟢 Context Therapeutics is trading 5% up today — no confirmed catalyst identified
Context Therapeutics is trading 5.17% up now at $0.53 on August 14, 2026, with no new company-specific announcement, filing, earnings release, or analyst...